Macrophage-Mediated Subversion of Anti-Tumour Immunity



Quaranta, Valeria and Schmid, Michael C ORCID: 0000-0002-3445-0013
(2019) Macrophage-Mediated Subversion of Anti-Tumour Immunity. CELLS, 8 (7). E747-.

Access the full-text of this item by clicking on the Open Access link.

Abstract

Despite the incredible clinical benefits obtained by the use of immune checkpoint blockers (ICBs), resistance is still common for many types of cancer. Central for ICBs to work is activation and infiltration of cytotoxic CD8<sup>+</sup> T cells following tumour-antigen recognition. However, it is now accepted that even in the case of immunogenic tumours, the effector functions of CD8<sup>+</sup> T cells are highly compromised by the presence of an immunosuppressive tumour microenvironment (TME) at the tumour site. Tumour-associated macrophages (TAMs) are among the most abundant non-malignant stromal cell types within the TME and they are crucial drivers of tumour progression, metastasis and resistance to therapy. TAMs are able to regulate either directly or indirectly various aspects of tumour immunity, including T cell recruitment and functions. In this review we discuss the mechanisms by which TAMs subvert CD8<sup>+</sup> T cell immune surveillance and how their targeting in combination with ICBs represents a very powerful therapeutic strategy.

Item Type: Article
Uncontrolled Keywords: macrophage, cancer, anti-tumour immunity, immunosuppression, immune checkpoint blockers
Depositing User: Symplectic Admin
Date Deposited: 24 Jul 2019 10:49
Last Modified: 24 Jan 2024 17:56
DOI: 10.3390/cells8070747
Open Access URL: https://doi.org/10.3390/cells8070747
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3050240